Skip to content

Hematotoxic Effects of Particulate Exposure

Hematotoxic Effects of Benzene and Doxorubicin

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00015483
Enrollment
Unknown
Registered
2001-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2006-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Hematotoxicity, Benzene, Bone Marrow

Brief summary

Hematotoxicity is caused by a number of agents such as a benzene by-product called hydroquinone and the antitumor agent doxorubicin. This is a basic research study, conducted using normal human donors, of mechanisms involved in hematotoxicity and of the protective response of human hematopoietic progenitor cells to hematotoxic agents. Tumor necrosis factor exposure protects these cells from a subsequent exposure to hematotoxic agents. The alteration of gene expression in these cells caused by tumor necrosis factor is being studied. Additionally, the tumor necrosis factor-induced biochemical pathways involved in protection of human hematopoietic progenitor cells will be studied.

Interventions

None listed

Sponsors

National Institute of Environmental Health Sciences (NIEHS)
Lead SponsorNIH

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy * nonsmoking * no history of hematologic disorder * not pregnant * no medications which suppress hematopoiesis

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026